News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
11 Results
Type
Article (3)
Press Release (8)
Section
Business (4)
Deals (1)
Drug Development (5)
News (8)
Policy (1)
Tag
Clinical research (4)
IPO (1)
NextGen Class of 2024 (1)
People (3)
Phase I (4)
Phase II (1)
Phase III (1)
Preclinical (1)
Regulatory (1)
Date
2020 (3)
2018 (2)
2017 (6)
Location
Asia (2)
Europe (1)
11 Results for "incysus".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Incysus Therapeutics Initiates Enrollment In Phase 1 Study Of A Genetically Modified Gamma Delta (γδ) T Cell Immunotherapy In Patients With Newly-diagnosed Glioblastoma
First-in-Patients Trial of Incysus’ Drug Resistant Immunotherapy (DRI) Technology Is Being Conducted at The University of Alabama At Birmingham (UAB)
March 1, 2020
·
5 min read
Drug Development
Incysus Announces FDA Approval of IND Application for a Phase 1 Study of a Gamma-Delta (γδ) T Cell Leukemia and Lymphoma Immunotherapy
Incysus Announces FDA Approval of IND Application for a Phase I Study of a Gamma-Delta T Cell Leukemia and Lymphoma Immunotherapy
October 17, 2017
·
2 min read
Business
Incysus Announces Formation Of Scientific Advisory Board
August 24, 2017
·
3 min read
Drug Development
Incysus Presents Positive Data on Drug-Resistant Immunotherapy for Glioblastoma at AACR CNS Immunotherapy Conference
Dr. Lamb, presented new data on the Company’s adoptive cell therapy program for glioblastoma.
February 14, 2018
·
3 min read
Business
Incysus Announces Appointment of Siraj Ali, MD, PhD to Its Scientific Advisory Board
Dr. Ali joins a distinguished group of oncologists and immunologists providing their expertise and guidance.
December 1, 2017
·
2 min read
Drug Development
Incysus Submits Second Investigational New Drug Application for Gamma-Delta T Cell Immunotherapy Candidate
IND to support Phase 1 safety and activity study of Drug Resistant Immunotherapy for the treatment of glioblastoma.
January 9, 2018
·
2 min read
Incysus Granted European Patent Covering Its Drug Resistant Immunotherapy (DRI) Technology
April 13, 2017
·
2 min read
Drug Development
Incysus Submits Investigational New Drug (IND) Application For Allogeneic Gamma-Delta T Cell Immunotherapy For Leukemia And Lymphoma
September 19, 2017
·
2 min read
Deals
Biopharma Money on the Move: October 15-21
Find out which biopharma companies are raking in the cash this week, as companies from around the globe provide updates on their financing rounds and IPOs.
October 22, 2020
·
4 min read
·
Kate Goodwin
Bio NC
Clinical Catch-Up: February 24-28
The month of February ended with a flurry of clinical trial announcements. Here’s a look.
February 28, 2020
·
8 min read
·
Mark Terry
1 of 2
Next
